Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients and pharmaceutical intermediates, cooperative R & D, custom manufacturing, sales and service as well as import of pharmaceutical raw materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic pharmaceutical companies, including pharmaceutical applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provides factory quality management system certification consulting services.
Internationally, we has long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provides API registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our company's various chemical qualifications and certificates are complete, there are a variety of pharmaceutical intermediates and precursor chemicals, and most of the common dangerous goods business qualifications, and have complete import and export qualifications, the company's products are sold all over the world, and Acting for the import and export of various products such as hazardous chemicals.
The company is mainly engaged in wholesale, retail, biological products, pharmaceutical intermediates, first-class medical equipment, petroleum products, rubber products, plastic products, biological reagents, biochemical testing reagents and consumables, chemical reagents; pharmaceutical operations (operating with valid licenses) Import and export of goods and technology (except for projects prohibited by national laws and administrative regulations, and laws and administrative regulations stipulate that projects that restrict operations can only be operated after obtaining a permit). (Projects subject to approval according to law may be operated after approval by relevant departments)
Shandong Xinhua Pharmaceutical Co., Ltd.
- Profile: Founded in 1943, headquartered in Zibo, Shandong, a key Chinese production and export base for antipyretic analgesics, with a national-level enterprise technology center.
- Key Products:
- NSAID APIs: Aspirin, metamizole, ibuprofen, with aspirin capacity leading globally (over 30,000 tons/year).
- Specialty APIs: Diclofenac sodium, indomethacin, widely used in topical anti-inflammatory preparations (creams, patches).
- Supply Advantages: Mature processes, strong cost control, high purity (aspirin ≥99.5%), certified by GMP in multiple countries, supplying Bayer, Johnson & Johnson, etc.
Shijiazhuang Pharmaceutical Group Co., Ltd.
- Profile: Headquartered in Shijiazhuang, Hebei, a top 100 Chinese pharmaceutical enterprise covering APIs, innovative drugs, and generic drugs with multiple production bases.
- Key Products:
- Steroid APIs: Prednisone, methylprednisolone, etc., using microbial transformation for high yield and purity.
- NSAID APIs: Paracetamol, with an annual capacity of over 100,000 tons, supplying 60% of the global market.
- Supply Advantages: Vertical integrated industry chain, full-process control from intermediates to APIs, significant cost advantage, quality complying with ICH Q7 standards.
Sinopharm Group Co., Ltd.
- Profile: A central directly affiliated large pharmaceutical health group covering R&D, production, and distribution, with multiple API production bases.
- Key Products:
- Steroid APIs: Hydrocortisone, betamethasone, supplying domestic formulators and global markets with internationally advanced processes.
- Biologics APIs: Recombinant human interferon (anti-inflammatory & antiviral), pre-certified by WHO for immunomodulatory drugs.
- Supply Advantages: State-owned background ensures supply stability, API production complies with Chinese GMP and international standards, suitable for long-term cooperation with large pharmaceutical companies.
Hubei Hengdi Pharmaceutical Co., Ltd.
- Profile: Located in Jingmen, Hubei, focusing on R&D and production of NSAID and cardiovascular APIs, a major domestic supplier of ibuprofen and dexibuprofen.
- Key Products:
- NSAID APIs: Ibuprofen (10,000 tons/year), dexibuprofen (optical purity >99.5%), for oral and topical gels.
- Specialty APIs: Etoricoxib (COX-2 inhibitor API), supplying domestic innovative and generic pharmaceutical enterprises.
- Supply Advantages: Focused on niche markets, advanced technologies like asymmetric synthesis for dexibuprofen, lower costs than traditional resolution methods, strong product competitiveness.
Shanghai Desano Biomedical Co., Ltd.
- Profile: Headquartered in Shanghai, a key Chinese supplier of anti-HIV, antiviral, and NSAID APIs, with multiple overseas production bases.
- Key Products:
- NSAID APIs: Naproxen, ketoprofen, certified by EU CEP, with impurity control reaching international leading levels (naproxen impurities ≤0.1%).
- Steroid APIs: Fluticasone (respiratory anti-inflammatory API), supplying AstraZeneca, GSK, etc.
- Supply Advantages: High R&D investment, expert in complex API synthesis (chiral drugs), offering customized production to meet special needs.
Jiangsu Hengrui Medicine Co., Ltd.
- Profile: Headquartered in Lianyungang, Jiangsu, a leading Chinese innovative drug enterprise also engaged in API R&D, with a national-level enterprise technology center.
- Key Products:
- Biologics APIs: Adalimumab (Humira biosimilar API), for rheumatoid arthritis, etc., processes close to original drugs.
- NSAID APIs:Imrecoxib, selective COX-2 inhibitor API, self-developed, under patent protection, supplying Hengrui and partners.
- Supply Advantages: Strong innovation, integrated API-formulation development, high quality standards (biologics activity ≥95% of original drugs), suitable for high-end formulators.
Zhejiang Xianju Pharmaceutical Co., Ltd.
- Profile: Headquartered in Taizhou, Zhejiang, a specialized Chinese steroid manufacturer with a complete steroid hormone industry chain.
- Key Products:
- Steroid Anti-inflammatory APIs: Dexamethasone, triamcinolone acetonide, fluocinolone, etc., annual steroid API production over 2,000 tons, processes including chemical synthesis and biotransformation.
- Specialty APIs: Mometasone furoate (topical anti-inflammatory & anti-allergic API), for eczema/dermatitis preparations, supplying domestic OTC.
- Supply Advantages: Complete steroid API portfolio, full-chain production from basic materials (e.g., diosgenin) to finished APIs, excellent cost control.
Hebei Jiuzheng Pharmaceutical Co., Ltd.
- Profile: Located in Shijiazhuang, Hebei, focusing on NSAID and antipyretic analgesic APIs, a major domestic supplier of metamizole and aminopyrine.
- Key Products:
- NSAID APIs: Metamizole (5,000 tons/year), aminopyrine, antipyrine, for compound cold and anti-inflammatory analgesic preparations.
- Intermediates: 4-Aminoantipyrine (key intermediate for NSAIDs), supplying domestic API enterprises.
- Supply Advantages: Traditional API supplier, mature processes, competitive prices, suitable for generic and small-to-medium formulators.
Guangdong Jiaying Pharmaceutical Co., Ltd.
- Profile: Headquartered in Meizhou, Guangdong, starting with traditional Chinese medicine, recently entering chemical APIs, focusing on topical anti-inflammatory API production.
- Key Products:
- Topical Anti-inflammatory APIs: Diclofenac sodium, ibuprofen (topical grade), for gels and patches, strict impurity control (heavy metals ≤10ppm).
- TCM Anti-inflammatory Ingredients: Paeonol (extracted from cortex moutan), for TCM anti-inflammatory ointments, with anti-inflammatory and analgesic effects.
- Supply Advantages: Focused on topical API formulations, strong compatibility, offering customized technical parameters (particle size, solubility), meeting special needs of topical preparations.
Core Advantages of Chinese Anti-inflammatory API Suppliers:
1. Production Scale: Account for >70% global NSAID API capacity (ibuprofen, aspirin) and >50% steroid API capacity.
2. Technological Processes: Some enterprises master advanced technologies (chiral synthesis, microbial transformation), with API purity and stability meeting international standards.
3. Cost Advantage: Relying on complete industry chains (chemical intermediates), production costs 30%-50% lower than European/American counterparts.
4. Regulatory Compliance: Over 50 enterprises certified by FDA, EMA, WHO-GMP, allowing direct access to international markets.